CNBX Pharmaceuticals Inc. Price Chart
CNBX Pharmaceuticals Inc. 8C8.SG Financial and Trading Overview
| CNBX Pharmaceuticals Inc. stock price | 0.07 EUR |
| Previous Close | 0.07 EUR |
| Open | 0.08 EUR |
| Bid | 0.07 EUR x 1800000 |
| Ask | 0.08 EUR x 1800000 |
| Day's Range | 0.07 - 0.08 EUR |
| 52 Week Range | 0.06 - 0.19 EUR |
| Volume | 5K EUR |
| Avg. Volume | 5.71K EUR |
| Market Cap | 11.45M EUR |
| Beta (5Y Monthly) | 1.448591 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.616 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8C8.SG Valuation Measures
| Enterprise Value | 42.61M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -27.842 |
Trading Information
CNBX Pharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 1.448591 |
| 52-Week Change | -62.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.19 EUR |
| 52 Week Low | 0.06 EUR |
| 50-Day Moving Average | 0.07 EUR |
| 200-Day Moving Average | 0.11 EUR |
8C8.SG Share Statistics
| Avg. Volume (3 month) | 5.71K EUR |
| Avg. Daily Volume (10-Days) | 5.5K EUR |
| Shares Outstanding | 149.44M |
| Float | 4.19M |
| Short Ratio | N/A |
| % Held by Insiders | 14.58% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -133.61% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1530469 EUR |
| Net Income Avi to Common (ttm) | -4143349 EUR |
| Diluted EPS (ttm) | -3.616 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 47.75K EUR |
| Total Cash Per Share (mrq) | 0.01 EUR |
| Total Debt (mrq) | 1.54M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.044 |
| Book Value Per Share (mrq) | -0.91 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -639317 EUR |
| Levered Free Cash Flow (ttm) | -1338 EUR |
Profile of CNBX Pharmaceuticals Inc.
| Country | Germany |
| State | MD |
| City | Bethesda |
| Address | #3 Bethesda Metro Center |
| ZIP | 20814 |
| Phone | 877 424 2429 |
| Website | https://www.cnbxpharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 3 |
CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.
Q&A For CNBX Pharmaceuticals Inc. Stock
What is a current 8C8.SG stock price?
CNBX Pharmaceuticals Inc. 8C8.SG stock price today per share is 0.07 EUR.
How to purchase CNBX Pharmaceuticals Inc. stock?
You can buy 8C8.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CNBX Pharmaceuticals Inc.?
The stock symbol or ticker of CNBX Pharmaceuticals Inc. is 8C8.SG.
How many shares does CNBX Pharmaceuticals Inc. have in circulation?
The max supply of CNBX Pharmaceuticals Inc. shares is 165.98M.
What is CNBX Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
CNBX Pharmaceuticals Inc. PE Ratio is now.
What was CNBX Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
CNBX Pharmaceuticals Inc. EPS is -3.616 EUR over the trailing 12 months.